Firefly Neuroscience (AIFF) Operating Expenses (2010 - 2026)

Firefly Neuroscience has reported Operating Expenses for 16 years, with the latest figure at $2.2 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 16.72% year-over-year to $2.2 million in Q2 2026; TTM through Jun 2026 was $9.9 million, a 23.87% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, down 6.5% from the prior year.
• Operating Expenses was $2.2 million for Q2 2026 at Firefly Neuroscience, roughly flat from $2.2 million in the prior quarter.
• The five-year high for Operating Expenses was $6.7 million in Q3 2024, with the low at $670000.0 in Q3 2023.
• Average Operating Expenses over 5 years is $2.3 million, with a median of $2.1 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 64.87% in 2023, then jumped 895.97% in 2024.
• Over 5 years, Operating Expenses stood at $1.5 million in 2022, then increased by 3.23% to $1.6 million in 2023, then soared by 320.74% to $6.7 million in 2024, then sank by 59.79% to $2.7 million in 2025, then slipped by 17.0% to $2.2 million in 2026.
• The last three Operating Expenses figures came in at $2.2 million (Q2 2026), $2.2 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.